Skip to main content

Table 1 Prevalence of stimulant use among Flemish students 1965-2005

From: Stimulant medication use among Flemish students: results from an exploring secondary data analysis1965-2005

Study

Prové & Varenne

(1965)

Van de Voorde et al. (1967-1968)

Waege et al.

(1993)

Waege et al.

(1993)

Rosiers & Van Hal (2005)

Rosiers & Van Hal (2005)

Number of respondents

(n = 1,848)

(n = 6,982)

(n = 1,936)

(n = 2,007)

(n = 1,501)

(n = 1,501)

Male/Female

M: 83.7%

F: 16.3%

M: 77.1%

F: 22.9%

M: 50.9%/F: 49,1%

M: 46.9%/F: 53.1%

Residential/

commuter

R: 46.3%

C: 53.7%

R: 81.4%

C: 18.6%

R: 81.6%

C: 18.4%

R: 29.0%/C: 71.0%

Reference period

Exams

Last year

Exams

Pre-exams

Exams

Last year

Prevalence (%)

5.7%

5.7%

9.5%

3.6%

2.6%

2.9%

Numbers of stimulant users

(n = 106)

(n = 395)

(n = 183)

(n = 73)

(n = 39)

(n = 44)

Gender:

ns

ns

ns

-

-

**

Male (%)

5.4%

5.9%

8.9%

  

4.3%

Female (%)

7.6%

4.7%

10.4%

  

1.8%

Level of

significance

p = 0.12

p = 0.07

p = 0.27

-

-

p = 0.004

Living status:

**

*

***

-

-

*

Residential (%)

7.6%

6.0%

13.2%

  

4.7%

Commuter (%)

4.1%

4.3%

5.6%

  

2.4%

Level of significance

p = 0.001

p = 0.04

p < 0.001

-

-

p = 0.04

Most popular products

Rilatine® (38.7%)

Rilatine® (35.4%)

Catovit®(80%)

Captagon® (14%)

-

  1. *** p < 0.001
  2. ** p < 0.01
  3. * p < 0.05
  4. ns not significant (p ≥ 0.05)